Pelvic Neoplasms

9 registered clinical trials studyying Pelvic Neoplasms — 1 currently recruiting.

Status	Trial	Sponsor	Phase
Completed	Oral Iohexol in the Management of Chylous Ascites After After Retroperitoneal or Extended Lymphadenectomy NCT06820320	Cancer Institute and Hospital, Chinese Academy of Medical Sciences	Phase 2
Withdrawn	Magnetic Resonance-guided High-Intensity Focused Ultrasound (MR-HIFU) Used for Mild Hyperthermia NCT03007771	Washington University School of Medicine	Phase 1
Recruiting	Cohort of Patients With Pelvic Gynecological Cancer: Constitution of a Collection of Biological Samples With R NCT03622983	Centre Hospitalier Intercommunal Creteil	—
Unknown	Malignant Pediatric Pelvic Tumors: A Retrospective Study NCT02557256	Assiut University	—
Completed	Treatment of Hemorrhagic Radiation Proctitis Using the Halo System NCT01103492	University Hospitals Cleveland Medical Center	N/A
Completed	Phase 1 Dose Escalation Study of SN2310 Injectable Emulsion in Patients With Advanced Solid Tumors NCT00385177	Achieve Life Sciences	Phase 1
Completed	An Ovarian, Primary Peritoneal or Fallopian Tube Cancer Study for Patients That Have Not Received Prior Chemot NCT00191646	Eli Lilly and Company	Phase 3
Completed	A Randomized Trial for Patients With Platinum Resistant Ovarian, Fallopian or Primary Peritoneal Cancer. NCT00191607	Eli Lilly and Company	Phase 3
Completed	Determination of a Safe Dose of Optison in Pediatric Patients With Solid Tumors NCT00186953	St. Jude Children's Research Hospital	Phase 1